BioSpace News Archive

RXi Pharmaceuticals Corporation reported its financial results for the fourth quarter and year ended December 31, 2017 and provided a business update.

Apollo Medical Holdings Inc. announced that it will be presenting at Needham & Company’s 17th Annual Healthcare Conference on March 28, 2018. The Company will also be hosting investor meetings.

A San Antonio jury today returned a unanimous verdict in favor of Allergy & Asthma Network, the defendant in a federal antitrust lawsuit brought by United Allergy Services in early 2014.

In a recent op-ed in Fortune, Joe Biden expounded upon his call to improve access to healthcare information for patients.

Aspiring physician says specialty master’s program in healthcare services management will give him the business skills necessary to run a practice effectively.

The Honourable Ginette Petitpas Taylor, Federal Minister of Health, will hold a media availability in the Foyer of the House of Commons following Question Period at approximately 3:15 PM (EDT), March 27, 2018.

The provincial government is providing financial support to eligible individuals interested in taking part in the Collège communautaire du Nouveau-Brunswick’s (CCNB) cannabis cultivation program in Campbellton, in partnership with Zenabis Ltd.

A study conducted at the University of Texas Southwestern Medical Center has demonstrated that TASIN (Truncated APC Selective INhibitor), a recently identified small molecule, selectively kills colorectal cancer cells (CRC) by inducing endoplasmic reticulum (ER) stress which leads to activation of the pro-apoptotic JNK pathway and PARP cleavage.

Kaiser Permanente Washington welcomes Tim Shriver, international chairman of the board of directors for Special Olympics, and the Washington team of 247 Special Olympics athletes for a send-off celebration Tuesday.

ImmunoGen, released positive efficacy and tolerability data from its FORWARD II trial of its mirvetuximab soravtansine in combination with Merck’s Keytruda in platinum-resistant epithelial ovarian cancer (EOC). Shares jumped almost 12 percent in premarket trading.